vs
Side-by-side financial comparison of reAlpha Tech Corp. (AIRE) and Mind Medicine (MindMed) Inc. (DFTX). Click either name above to swap in a different company.
Mind Medicine (MindMed) Inc. is the larger business by last-quarter revenue ($906.0K vs $895.3K, roughly 1.0× reAlpha Tech Corp.). reAlpha Tech Corp. runs the higher net margin — -541.6% vs -2634.0%, a 2092.4% gap on every dollar of revenue. On growth, reAlpha Tech Corp. posted the faster year-over-year revenue change (70.1% vs -16.1%).
reAlpha Tech Corp is a proptech firm that leverages artificial intelligence to identify, acquire, and operate high-yield short-term residential rental properties primarily across the United States. It provides tech-powered property management solutions to enhance guest experiences and maximize returns for individual and institutional real estate investors.
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.
AIRE vs DFTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2023
| Metric | | |
|---|---|---|
| Revenue | $895.3K | $906.0K |
| Net Profit | $-4.8M | $-23.9M |
| Gross Margin | 62.7% | — |
| Operating Margin | -507.8% | -2450.8% |
| Net Margin | -541.6% | -2634.0% |
| Revenue YoY | 70.1% | -16.1% |
| Net Profit YoY | 76.9% | -386.7% |
| EPS (diluted) | $-0.02 | $-0.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $895.3K | — | ||
| Q3 25 | $1.4M | — | ||
| Q2 25 | $1.3M | — | ||
| Q1 25 | $925.6K | — | ||
| Q4 24 | $526.4K | — | ||
| Q3 24 | $339.2K | — | ||
| Q2 24 | $62.4K | — | ||
| Q1 24 | $20.4K | — |
| Q4 25 | $-4.8M | — | ||
| Q3 25 | $-5.8M | — | ||
| Q2 25 | $-4.1M | — | ||
| Q1 25 | $-2.8M | — | ||
| Q4 24 | $-21.0M | — | ||
| Q3 24 | $-2.1M | — | ||
| Q2 24 | $-1.5M | — | ||
| Q1 24 | $-1.4M | — |
| Q4 25 | 62.7% | — | ||
| Q3 25 | 51.9% | — | ||
| Q2 25 | 49.6% | — | ||
| Q1 25 | 56.0% | — | ||
| Q4 24 | 71.1% | — | ||
| Q3 24 | 66.6% | — | ||
| Q2 24 | 70.7% | — | ||
| Q1 24 | 10.7% | — |
| Q4 25 | -507.8% | — | ||
| Q3 25 | -342.4% | — | ||
| Q2 25 | -326.5% | — | ||
| Q1 25 | -261.7% | — | ||
| Q4 24 | -524.6% | — | ||
| Q3 24 | -479.1% | — | ||
| Q2 24 | -1939.6% | — | ||
| Q1 24 | -6397.0% | — |
| Q4 25 | -541.6% | — | ||
| Q3 25 | -400.1% | — | ||
| Q2 25 | -328.3% | — | ||
| Q1 25 | -307.9% | — | ||
| Q4 24 | -3994.4% | — | ||
| Q3 24 | -618.6% | — | ||
| Q2 24 | -2370.9% | — | ||
| Q1 24 | -6946.9% | — |
| Q4 25 | $-0.02 | — | ||
| Q3 25 | $-0.07 | — | ||
| Q2 25 | $-0.08 | — | ||
| Q1 25 | $-0.06 | — | ||
| Q4 24 | $-0.47 | — | ||
| Q3 24 | $-0.05 | — | ||
| Q2 24 | $-0.03 | — | ||
| Q1 24 | $-0.03 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.8M | $99.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $11.5M | $78.1M |
| Total Assets | $21.7M | $124.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.8M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $587.3K | — | ||
| Q1 25 | $1.2M | — | ||
| Q4 24 | $3.1M | — | ||
| Q3 24 | $7.1M | — | ||
| Q2 24 | $3.7M | — | ||
| Q1 24 | $4.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $152.9K | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $241.1K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $11.5M | — | ||
| Q3 25 | $10.9M | — | ||
| Q2 25 | $-1.1M | — | ||
| Q1 25 | $-972.3K | — | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $22.5M | — | ||
| Q2 24 | $22.2M | — | ||
| Q1 24 | $23.3M | — |
| Q4 25 | $21.7M | — | ||
| Q3 25 | $19.7M | — | ||
| Q2 25 | $15.5M | — | ||
| Q1 25 | $18.5M | — | ||
| Q4 24 | $12.0M | — | ||
| Q3 24 | $34.2M | — | ||
| Q2 24 | $24.6M | — | ||
| Q1 24 | $25.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.3M | $-20.6M |
| Free Cash FlowOCF − Capex | $-11.3M | — |
| FCF MarginFCF / Revenue | -1262.7% | — |
| Capex IntensityCapex / Revenue | 4.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-20.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.3M | — | ||
| Q3 25 | $-4.2M | — | ||
| Q2 25 | $-2.3M | — | ||
| Q1 25 | $-2.3M | — | ||
| Q4 24 | $-6.0M | — | ||
| Q3 24 | $-1.3M | — | ||
| Q2 24 | $-1.0M | — | ||
| Q1 24 | $-1.5M | — |
| Q4 25 | $-11.3M | — | ||
| Q3 25 | $-4.3M | — | ||
| Q2 25 | $-2.3M | — | ||
| Q1 25 | $-2.3M | — | ||
| Q4 24 | $-6.1M | — | ||
| Q3 24 | $-1.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -1262.7% | — | ||
| Q3 25 | -294.1% | — | ||
| Q2 25 | -187.5% | — | ||
| Q1 25 | -246.4% | — | ||
| Q4 24 | -1150.2% | — | ||
| Q3 24 | -372.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 4.8% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
